The DOI matches its Crossref record; 354 of the 354 references it cites were found in a registry or an index.
Basal lamina changes in neurodegenerative disorders
Open accessAbstract
Background: Neurodegenerative disorders are a group of age-associated diseases characterized by progressive degeneration of the structure and function of the CNS. Two key pathological features of these disorders are blood-brain barrier (BBB) breakdown and protein aggregation. Main body: The BBB is composed of various cell types and a non-cellular component---the basal lamina (BL). Although how different cells affect the BBB is well studied, the roles of the BL in BBB maintenance and function remain largely unknown. In addition, located in the perivascular space, the BL is also speculated to regulate protein clearance via the meningeal lymphatic/glymphatic system. Recent studies from our laboratory and others have shown that the BL actively regulates BBB integrity and meningeal lymphatic/glymphatic function in both physiological and pathological conditions, suggesting that it may play an important role in the pathogenesis and/or progression of neurodegenerative disorders. In this review, we focus on changes of the BL and its major components during aging and in neurodegenerative disorders, including Alzheimer’s disease (AD), Parkinson’s disease (PD), and amyotrophic lateral sclerosis (ALS). First, we introduce the vascular and lymphatic systems in the CNS. Next, we discuss the BL and its major components under homeostatic conditions, and summarize their changes during aging and in AD, PD, and ALS in both rodents and humans. The functional significance of these alterations and potential therapeutic targets are also reviewed. Finally, key challenges in the field and future directions are discussed. Conclusions: Understanding BL changes and the functional significance of these changes in neurodegenerative disorders will fill the gap of knowledge in the field. Our goal is to provide a clear and concise review of the complex relationship between the BL and neurodegenerative disorders to stimulate new hypotheses and further research in this field.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Figures



Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Breakdown of the blood-brain barrier (BBB) is an early biomarker of human cognitive decline”
From ApoE4 reduction: An emerging and promising therapeutic strategy for Alzheimer's disease (2022) · cites this paper as Nguyen et al 2021
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Items 201–354 of 354
Hawkes, C. A., Gatherer, M., Sharp, M. M., Dorr, A. E., Yuen, H. M., Kalaria, R. N., Weller, R. O., & Carare, R. O. (2013) · Aging Cell · doi:10.1111/acel.12045 · Cited by 157
DECREASED mRNA EXPRESSION OF TIGHT JUNCTION PROTEINS IN LUMBAR SPINAL CORDS OF PATIENTS WITH ALS
Henkel, J. S., Beers, D. R., Wen, S., Bowser, R., & Appel, S. H. (2009) · Neurology · doi:10.1212/wnl.0b013e3181a41228 · Cited by 153
Perlecan a multifunctional extracellular proteoglycan scaffold
Farach‐Carson, M. C., & Carson, D. D. (2007) · Glycobiology · doi:10.1093/glycob/cwm043 · Cited by 153
Jeanne, M., Jorgensen, J., & Gould, D. B. (2015) · Circulation · doi:10.1161/circulationaha.114.013395 · Cited by 153
Lang, A. E. (2011) · Movement Disorders · doi:10.1002/mds.23609 · Cited by 152
Blood-CNS Barrier Impairment in ALS patients versus an animal model
Garbuzova-Davis, S. N., & Sanberg, P. R. (2014) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2014.00021 · Cited by 152
Incidence of cerebral microbleeds in preclinical Alzheimer disease
Yates, P. A., Desmond, P. M., Phal, P. M., Steward, C., Szoeke, C., Salvado, O., Ellis, K. A., Martins, R. N., Masters, C. L., Ames, D., et al. (2014) · Neurology · doi:10.1212/wnl.0000000000000285 · Cited by 150
Xia, M., Yang, L., Sun, G., Qi, S., & Li, B. (2017) · Psychopharmacology · doi:10.1007/s00213-016-4473-9 · Cited by 149
Thickening of the basement membrane of cortical capillaries in Alzheimer's disease
Mancardi, G., Perdelli, F., Rivano, C., Leonardi, A., & Bugiani, O. (1980) · Acta Neuropathologica · doi:10.1007/bf00692225 · Cited by 147
Blood–brain barrier disruption induces in vivo degeneration of nigral dopaminergic neurons
Rite, I., Machado, A., Cano, J., & Venero, J. L. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2007.04567.x · Cited by 147
Kim, S. Y., Buckwalter, M., Soreq, H., Vezzani, A., & Kaufer, D. (2012) · Epilepsia · doi:10.1111/j.1528-1167.2012.03701.x · Cited by 145
The role of pericytic laminin in blood brain barrier integrity maintenance
Gautam, J., Zhang, X., & Yao, Y. (2016) · Scientific Reports · doi:10.1038/srep36450 · Cited by 144
Self-citationAgrin Is a Major Heparan Sulfate Proteoglycan Accumulating in Alzheimer's Disease Brain
Verbeek, M. M., Otte‐Höller, I., van den Born, J., van den Heuvel, L. P. W. J., David, G., Wesseling, P., & de Waal, R. M. W. (1999) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)65529-0 · Cited by 141
Sado, Y., Kagawa, M., Naito, I., Ueki, Y., Seki, T., Momota, R., Oohashi, T., & Ninomiya, Y. (1998) · The Journal of Biochemistry · doi:10.1093/oxfordjournals.jbchem.a022003 · Cited by 140
Schymeinsky, J., Nedbal, S., Miosge, N., Pöschl, E., Rao, C., Beier, D. R., Skarnes, W. C., Timpl, R., & Bader, B. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.19.6820-6830.2002 · Cited by 140
Tilling, T., Engelbertz, C. M., Decker, S., Korte, D., Hüwel, S., & Galla, H. (2002) · Cell and Tissue Research · doi:10.1007/s00441-002-0604-1 · Cited by 138
Blood–Brain Barrier Dysfunction as a Hallmark Pathology in Chronic Traumatic Encephalopathy
Doherty, C. P., O’Keefe, E., Wallace, E., Loftus, T., Keaney, J., Kealy, J., Humphries, M. M., Molloy, M. G., Meaney, J. F., Farrell, M., et al. (2016) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/nlw036 · Cited by 135
Chao, Y.-X., He, B., & Tay, S. (2009) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2009.09.003 · Cited by 133
Shams, S., Martola, J., Granberg, T., Li, X., Shams, M., Fereshtehnejad, S. M., Cavallin, L., Aspelin, P., Kristoffersen-Wiberg, M., & Wahlund, L. O. (2015) · American Journal of Neuroradiology · doi:10.3174/ajnr.a4176 · Cited by 132
Snow, A. D., Sekiguchi, R., Nochlin, D., Kalaria, R. N., & Kimata, K. (1994) · PubMed Central · Cited by 132
Dong, L., Chen, Y., Lewis, M. E., Hsieh, J.-C., Reing, J. E., Chaillet, J. R., Howell, C. Y., Melhem, M. F., Inoué, S., Kuszak, J. R., et al. (2002) · Laboratory Investigation · doi:10.1097/01.lab.0000042240.52093.0f · Cited by 132
Vascular Basement Membrane Thickening in Diabetic Retinopathy
Roy, S., Ha, J., Trudeau, K. M., & Beglova, E. (2010) · Current Eye Research · doi:10.3109/02713683.2010.514659 · Cited by 132
Endothelial LRP1 protects against neurodegeneration by blocking cyclophilin A
Nikolakopoulou, A. M., Wang, Y., Ma, Q., Sagare, A. P., Montagne, A., Huuskonen, M. T., Rege, S. V., Kisler, K., Dai, Z., Körbelin, J., et al. (2021) · The Journal of Experimental Medicine · doi:10.1084/jem.20202207 · Cited by 131
Perlmutter, L. S., Chui, H. C., Saperia, D., & Athanikar, J. N. (1990) · Brain Research · doi:10.1016/0006-8993(90)91111-s · Cited by 131
Favor, J., Gloeckner, C. J., Janik, D., Klempt, M., Neuhäuser-Klaus, A., Pretsch, W., Schmahl, W., & Quintanilla-Fend, L. (2006) · Genetics · doi:10.1534/genetics.106.064733 · Cited by 129
Narindrasorasak, S., Lowery, D. E., Altman, R. A., Gonzalez‐DeWhitt, P. A., Greenberg, B. D., & Kisilevsky, R. (1992) · PubMed · Cited by 128
Sjogren, M. (2004) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.2003.019422 · Cited by 125
Coles, J. A., Myburgh, E., Brewer, J. M., & McMenamin, P. G. (2017) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2017.05.002 · Cited by 123
The Natural History of Alzheimer's Disease: A Brain Bank Study
Jost, B. C., & Grossberg, G. T. (1995) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.1995.tb07401.x · Cited by 123
Cerebrospinal Fluid Biomarkers of Neurovascular Dysfunction in Mild Dementia and Alzheimer'S Disease
Sweeney, M. D., Sagare, A. P., & Zlokovic, B. V. (2015) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.2015.76 · Cited by 122
Recommendations of the Alzheimer's Disease–Related Dementias Conference
Montine, T. J., Koroshetz, W. J., Babcock, D., Dickson, D. W., Galpern, W. R., Glymour, M. M., Greenberg, S. M., Hutton, M. L., Knopman, D. S., Kuzmichev, A. N., et al. (2014) · Neurology · doi:10.1212/wnl.0000000000000733 · Cited by 122
Changes in vascularization in substantia nigra pars compacta of monkeys rendered parkinsonian
Barcia, C., Bautista‐Hernández, V., Sánchez-Bahíllo, A., Fernández‐Villalba, E., Faucheux, B. A., Poza, M., Barreiro, A. F., Hirsch, É. C., & Herrero, M. T. (2005) · Journal of Neural Transmission · doi:10.1007/s00702-004-0256-2 · Cited by 120
Chen, Z.-L., Yao, Y., Norris, E. H., Kruyer, A., Jno-Charles, O. C., Akhmerov, A., & Strickland, S. (2013) · The Journal of Cell Biology · doi:10.1083/jcb.201212032 · Cited by 120
Self-citationDeposits of IgG and C3 in the spinal cord and motor cortex of ALS patients
Donnenfeld, H., Kascsak, R. J., & Bartfeld, H. (1984) · Journal of Neuroimmunology · doi:10.1016/0165-5728(84)90042-0 · Cited by 119
Identification of Sites in Domain I of Perlecan That Regulate Heparan Sulfate Synthesis
Dolan, M. A., Horchar, T., Rigatti, B. W., & Hassell, J. R. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.7.4316 · Cited by 119
Laminin: loss-of-function studies
Yao, Y. (2016) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-016-2381-0 · Cited by 118
Self-citationAlzheimer's disease and soluble Aβ
Wısnıewskı, T., Ghiso, J. A., & Frangione, B. (1994) · Neurobiology of Aging · doi:10.1016/0197-4580(94)90105-8 · Cited by 112
A critical analysis of the ‘amyloid cascade hypothesis’
A. Armstrong, R. (2014) · Folia Neuropathologica · doi:10.5114/fn.2014.45562 · Cited by 110
In vivo dynamics of innate immune sentinels in the CNS
Nayak, D., Zinselmeyer, B. H., Corps, K. N., & McGavern, D. B. (2012) · IntraVital · doi:10.4161/intv.22823 · Cited by 109
Murtomäki, S., Risteli, J., Risteli, L., Koivisto, U., Johansson, S., & Liesi, P. (1992) · Journal of Neuroscience Research · doi:10.1002/jnr.490320216 · Cited by 109
Fluid-Based Biomarkers for Amyotrophic Lateral Sclerosis
Vu, L. T., & Bowser, R. P. (2016) · Neurotherapeutics · doi:10.1007/s13311-016-0503-x · Cited by 108
Reduction of the cerebrovascular volume in a transgenic mouse model of Alzheimer's disease
Bourasset, F., Ouellet, M., Tremblay, C., Julien, C., Do, T. M., Oddo, S., LaFerla, F., & Calon, F. (2009) · Neuropharmacology · doi:10.1016/j.neuropharm.2009.01.006 · Cited by 106
Blood-brain barrier dysfunction in Binswanger’s disease; an immunohistochemical study
Akiguchi, I., Tomimoto, H., Suenaga, T., Wakita, H., & Budka, H. (1998) · Acta Neuropathologica · doi:10.1007/s004010050768 · Cited by 104
Donahue, J. E., Berzin, T. M., Rafii, M. S., Glass, D. J., Yancopoulos, G. D., Fallon, J. R., & Stopa, E. G. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.11.6468 · Cited by 103
van Horssen, J., Otte‐Höller, I., David, G., Maat–Schieman, M. L. C., van den Heuvel, L. P., Wesseling, P., de Waal, R. M., & Verbeek, M. M. (2001) · Acta Neuropathologica · doi:10.1007/s004010100414 · Cited by 103
Heringa, S. M., on behalf of the Utrecht Vascular Cognitive Impairment (VCI) Study Group, Reijmer, Y. D., Leemans, A., Koek, H. L., Kappelle, L. J., & Biessels, G. J. (2013) · Journal of Alzheimer's Disease · doi:10.3233/jad-130542 · Cited by 100
High Prevalence of Cerebral Microbleeds at 7Tesla MRI in Patients with Early Alzheimer's Disease
Brundel, M., Heringa, S. M., de Bresser, J., Koek, H. L., Zwanenburg, J. J. M., Kappelle, L. J., Luijten, P. R., & Biessels, G. J. (2012) · Journal of Alzheimer's Disease · doi:10.3233/jad-2012-120364 · Cited by 97
Kang, S. H., & Kramer, J. M. (2000) · Molecular Biology of the Cell · doi:10.1091/mbc.11.11.3911 · Cited by 96
Hopf, M., Göhring, W., Mann, K., & Timpl, R. (2001) · Journal of Molecular Biology · doi:10.1006/jmbi.2001.4878 · Cited by 95
Nguyen, N. M., Miner, J. H., Pierce, R. A., & Senior, R. M. (2002) · Developmental Biology · doi:10.1006/dbio.2002.0658 · Cited by 94
Perlecan regulates pericyte dynamics in the maintenance and repair of the blood–brain barrier
Nakamura, K., Ikeuchi, T., Nara, K., Rhodes, C. S., Zhang, P., Chiba, Y., Kazuno, S., Miura, Y., Ago, T., Arikawa‐Hirasawa, E., et al. (2019) · The Journal of Cell Biology · doi:10.1083/jcb.201807178 · Cited by 93
The effects of cerebral amyloid angiopathy on integrity of the blood-brain barrier
Magaki, S., Tang, Z., Tung, S., Williams, C. K., Lo, D., Yong, W. H., Khanlou, N., & Vinters, H. V. (2018) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2018.06.004 · Cited by 93
Evidence of nidogen-2 compensation for nidogen-1 deficiency in transgenic mice
Miosge, N., Sasaki, T., & Timpl, R. (2002) · Matrix Biology · doi:10.1016/s0945-053x(02)00070-7 · Cited by 93
Gama Sosa, M. A., Gasperi, R. D., Rocher, A. B., Wang, A. C.-J., Janssen, W. G. M., Flores, T., Perez, G. M., Schmeidler, J., Dickstein, D. L., Hof, P. R., et al. (2010) · The American Journal of Pathology · doi:10.2353/ajpath.2010.090482 · Cited by 92
Loss of Nidogen-1 and -2 Results in Syndactyly and Changes in Limb Development
Böse, K., Nischt, R., Page, A. M., Bader, B., Paulsson, M., & Smyth, N. R. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m607886200 · Cited by 92
Uspenskaya, O., Martin Liebetrau, A., Herms, J. W., Danek, A., & Hamann, G. F. (2004) · BMC Neuroscience · doi:10.1186/1471-2202-5-37 · Cited by 89
Laminins and their receptors in the CNS
Nirwane, A. M., & Yao, Y. (2018) · Biological reviews/Biological reviews of the Cambridge Philosophical Society · doi:10.1111/brv.12454 · Cited by 88
Self-citationExtracellular matrix of secondary lymphoid organs impacts on B-cell fate and survival
Song, J., Lokmic‐Tomkins, Z., Lämmermann, T., Rolf, J., Wu, C., Zhang, X., Hallmann, R., Hannocks, M., Horn, N., Rüegg, M. A., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1218131110 · Cited by 86
Abnormal Expression of Collagen IV in Lens Activates Unfolded Protein Response Resulting in Cataract
Karagonlar, Z. F., Danysh, B. P., Bai, X., Gould, D. B., Kobayashi, T., & Duncan, M. K. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.060384 · Cited by 86
van de Haar, H. J., Jansen, J. F. A., Jeukens, C. R. L. P. N., Burgmans, S., van Buchem, M. A., Muller, M., Hofman, P. A. M., Verhey, F. R. J., van Osch, M. J. P., & Backes, W. H. (2017) · Medical Physics · doi:10.1002/mp.12328 · Cited by 85
Vascular Basement Membrane Pathology and Alzheimer's Disease
Zarow, C., Barrón, E., Chui, H. C., & Perlmutter, L. S. (1997) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1997.tb48467.x · Cited by 85
Primary structure and high expression of human agrin in basement membranes of adult lung and kidney
Groffen, A. J. A., Buskens, C. A. F., Kuppevelt, T. H. V., Veerkamp, J. H., Monnens, L. A. H., & van den Heuvel, L. P. W. J. (1998) · European Journal of Biochemistry · doi:10.1046/j.1432-1327.1998.2540123.x · Cited by 85
Yao, Y. (2018) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1177/0271678x18801467 · Cited by 84
Self-citationRole of clusterin in the brain vascular clearance of amyloid-β
Nelson, A. R., Sagare, A. P., & Zloković, B. V. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1711357114 · Cited by 79
Jucker, M., Tian, M., Norton, D. D., Sherman, C. A., & Kusiak, J. W. (1996) · Neuroscience · doi:10.1016/0306-4522(95)00496-3 · Cited by 77
String Vessel Formation is Increased in the Brain of Parkinson Disease
Yang, P., Pavlovic, D., Waldvogel, H. J., Dragunow, M., Synek, B. J., Turner, C. P., Faull, R. L. M., & Guan, J. (2015) · Journal of Parkinson s Disease · doi:10.3233/jpd-140454 · Cited by 77
Zhang, D., Yang, S., Toledo, E. M., Gyllborg, D., Saltó, C., Villaescusa, J. C., & Arenas, E. (2017) · Science Signaling · doi:10.1126/scisignal.aal4165 · Cited by 76
Altered microglia and neurovasculature in the Alzheimer's disease cerebellum
Singh‐Bains, M. K., Linke, V., Austria, M. D. R., Tan, A. Y. S., Scotter, E. L., Mehrabi, N. F., Faull, R. L. M., & Dragunow, M. (2019) · Neurobiology of Disease · doi:10.1016/j.nbd.2019.104589 · Cited by 74
Microvascular pathology and vascular basement membrane components in Alzheimer's disease
Perlmutter, L. S. (1994) · Molecular Neurobiology · doi:10.1007/bf02816103 · Cited by 73
Narindrasorasak, S., Altman, R. A., Gonzalez‐DeWhitt, P. A., Greenberg, B. D., & Kisilevsky, R. (1995) · PubMed · Cited by 73
Acute Ablation of Cortical Pericytes Leads to Rapid Neurovascular Uncoupling
Kisler, K., Nikolakopoulou, A. M., Sweeney, M. D., Lazić, D., Zhao, Z., & Zloković, B. V. (2020) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2020.00027 · Cited by 73
Glymphatic fluid transport controls paravascular clearance of AAV vectors from the brain
Murlidharan, G., Crowther, A., Reardon, R. A., Song, J., & Asokan, A. (2016) · JCI Insight · doi:10.1172/jci.insight.88034 · Cited by 72
Reduced perlecan in mice results in chondrodysplasia resembling Schwartz–Jampel syndrome
Bungartz, K. D., Sasaki, T., Aszódi, A., & Jacenko, O. (2007) · Human Molecular Genetics · doi:10.1093/hmg/ddl484 · Cited by 72
Mammadov, B., Mammadov, R., Guler, M. O., & Tekinay, A. B. (2012) · Acta Biomaterialia · doi:10.1016/j.actbio.2012.02.006 · Cited by 71
Lindahl, B., Westling, C., Giménez‐Gallego, G., Lindahl, U., & Salmivirta, M. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.43.30631 · Cited by 70
Majerová, P., Michalicová, A., Cente, M., Hanes, J., Vegh, J., Kittel, Á., Kosikova, N., Cigánková, V., Mihaljević, S., Jadhav, S., et al. (2019) · PLoS ONE · doi:10.1371/journal.pone.0217216 · Cited by 70
Webersinke, G., Bauer, H., Amberger, A., Zach, O., & Bauer, H. (1992) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(92)92285-6 · Cited by 69
Abnormalities in neural crest cell migration in laminin α5 mutant mice
Coles, E. G., Gammill, L. S., Miner, J. H., & Bronner-Fraser, M. E. (2005) · Developmental Biology · doi:10.1016/j.ydbio.2005.10.031 · Cited by 69
Alpha-synuclein deregulates the expression of COL4A2 and impairs ER-Golgi function
Paiva, I., Jain, G., Lázaro, D. F., Gotovac, K., Hentrich, T., Kerimoglu, C., Pinho, R., Szegő, É. M., Burkhardt, S., Capece, V., et al. (2018) · Neurobiology of Disease · doi:10.1016/j.nbd.2018.08.001 · Cited by 68
Altered Brain Uptake of Therapeutics in a Triple Transgenic Mouse Model of Alzheimer’s Disease
Mehta, D. C., Short, J. L., & Nicolazzo, J. A. (2013) · Pharmaceutical Research · doi:10.1007/s11095-013-1116-2 · Cited by 68
Buée, L., Ding, W., Anderson, J. P., Narindrasorasak, S., Kisilevsky, R., Boyle, N. J., Robakis, N. K. R. K., Delacourte, A., Greenberg, B., & Fillit, H. M. (1993) · Brain Research · doi:10.1016/0006-8993(93)90321-d · Cited by 66
Human Truncated Tau is Using a Different Mechanism from Amyloid-β to Damage the Blood-Brain Barrier
Kováč, A., Žilková, M., Deli, M. A., Žilka, N., & Novák, M. (2009) · Journal of Alzheimer s Disease · doi:10.3233/jad-2009-1197 · Cited by 65
Aging alters mRNA expression of amyloid transporter genes at the blood-brain barrier
Osgood, D., Miller, M. C., Messier, A. A., Gonzalez, L., & Silverberg, G. D. (2017) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2017.05.011 · Cited by 63
Differential distribution of laminins in Alzheimer disease and normal human brain tissue
Palu, E., & Liesi, P. (2002) · Journal of Neuroscience Research · doi:10.1002/jnr.10292 · Cited by 63
Functional interactions of neuronal heparan sulphate proteoglycans with laminin
Riopelle, R. J., & Dow, K. E. (1990) · Brain Research · doi:10.1016/0006-8993(90)91324-a · Cited by 63
Laminin inhibits amyloid-β-peptide fibrillation
Bronfman, F. C., Garrido, J., Alvarez, A. R., Morgan, C., & Inestrosa, N. C. (1996) · Neuroscience Letters · doi:10.1016/s0304-3940(96)13147-5 · Cited by 62
Loss of Endothelial Laminin α5 Exacerbates Hemorrhagic Brain Injury
Gautam, J., Miner, J. H., & Yao, Y. (2019) · Translational Stroke Research · doi:10.1007/s12975-019-0688-5 · Cited by 62
Self-citationAquaporin‐4 Overexpression in Rat ALS Model
Nicaise, C., Soyfoo, M. S., Authelet, M., Decker, R. D., Bataveljić, D., Delporte, C., & Pochet, R. (2008) · The Anatomical Record · doi:10.1002/ar.20838 · Cited by 61
Pericytic Laminin Maintains Blood-Brain Barrier Integrity in an Age-Dependent Manner
Gautam, J., Cao, Y., & Yao, Y. (2019) · Translational Stroke Research · doi:10.1007/s12975-019-00709-8 · Cited by 60
Self-citationBasement Membranes in Skin Are Differently Affected by Lack of Nidogen 1 and 2
Mokkapati, S., Baranowsky, A., Mirancea, N., Smyth, N. R., Breitkreutz, D., & Nischt, R. (2008) · Journal of Investigative Dermatology · doi:10.1038/jid.2008.65 · Cited by 60
Rauch, S. M., Huen, K. H. Y., Miller, M. C., Chaudry, H., Lau, M., Sanes, J. R., Johanson, C. E., Stopa, E. G., & Burgess, R. W. (2011) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e31823b0b12 · Cited by 59
Basement Membrane Changes in Ischemic Stroke
Kang, M., & Yao, Y. (2020) · Stroke · doi:10.1161/strokeaha.120.028928 · Cited by 59
Self-citationJendresen, C., Hao, C., Zhang, X. L., Vlodavsky, I., Nilsson, L. N. G., & Li, J. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.600569 · Cited by 59
The Targeted Deletion of the LAMC1 Gene
Smyth, N. R., Vatansever, S., MEYER, M., Frie, C., Paulsson, M., & EDGAR, D. (1998) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1998.tb10133.x · Cited by 57
Shimizu, H., Ghazizadeh, M., Sato, S., Oguro, T., & Kawanami, O. (2008) · Journal of Clinical Neuroscience · doi:10.1016/j.jocn.2008.04.009 · Cited by 57
Huang, D. Y., Weisgraber, K. H., Strittmatter, W. J., & Matthew, W. D. (1995) · Experimental Neurology · doi:10.1006/exnr.1995.1101 · Cited by 56
Coatti, G. C., Frangini, M., Valadares, M. C., Gomes, J. P., Lima, N. O., Cavaçana, N., Assoni, A. F., Pelatti, M. V., Birbrair, A., de Lima, A. C. P., et al. (2017) · Stem Cell Reviews and Reports · doi:10.1007/s12015-017-9752-2 · Cited by 56
Apolipoprotein E and LRP1 Increase Early in Parkinson's Disease Pathogenesis
Wilhelmus, M. M. M., Bol, J. G. J. M., van Haastert, E. S., Rozemüller, A. J. M., Bu, G., Drukarch, B., & Hoozemans, J. J. M. (2011) · American Journal Of Pathology · doi:10.1016/j.ajpath.2011.07.021 · Cited by 52
Hanyu, H., Asano, T., Tanaka, Y., Iwamoto, T., Takasaki, M., & Abe, K. (2002) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000058326 · Cited by 51
Bame, K. J., Danda, J., Hassall, A., & Tumova, S. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.27.17005 · Cited by 51
The α1.α2 Network of Collagen IV
Vanacore, R., Shanmugasundararaj, S., Friedman, D. B., Bondar, O., Hudson, B. G., & Sundaramoorthy, M. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m406344200 · Cited by 49
Yamadera, M., Fujimura, H., Inoue, K., Toyooka, K., Mori, C., Hirano, H., & Sakoda, S. (2015) · Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration · doi:10.3109/21678421.2015.1011663 · Cited by 49
Upregulated Expression of Heparanase and Heparanase 2 in the Brains of Alzheimer’s Disease
García, B., Martín, C., García‐Suárez, O., Muñiz-Alonso, B., Ordiales, H., Menéndez, S. F., Santos‐Juanes, J., Lorente-Gea, L., Castañón, S., Vicente‐Etxenausia, I., et al. (2017) · Journal of Alzheimer s Disease · doi:10.3233/jad-161298 · Cited by 48
Blood-spinal cord barrier leakage is independent of motor neuron pathology in ALS
Waters, S., Dieriks, B. V., Swanson, M. E. V., Zhang, Y., Grimsey, N. L., Murray, H. C., Turner, C. P., Waldvogel, H. J., Faull, R. L. M., An, J., et al. (2021) · Acta Neuropathologica Communications · doi:10.1186/s40478-021-01244-0 · Cited by 48
Cerebrospinal fluid aquaporin‐4‐immunoglobulin G disrupts blood brain barrier
Asgari, N., Berg, C. T., Mørch, M. T., Khorooshi, R., & Owens, T. (2015) · Annals of Clinical and Translational Neurology · doi:10.1002/acn3.221 · Cited by 46
Laminin immunohistochemistry in brain is dependent on method of tissue fixation
Jucker, M., Bialobok, P., Hagg, T., & Ingram, D. K. (1992) · Brain Research · doi:10.1016/0006-8993(92)91390-z · Cited by 46
Diseases of the neuromuscular junction
McConville, J. (2002) · Current Opinion in Pharmacology · doi:10.1016/s1471-4892(02)00156-x · Cited by 46
Cerebral microbleeds in early Alzheimer’s disease
Poliakova, T., Levin, O., Arablinskiy, A., Vasenina, E., & Zerr, I. (2016) · Journal of Neurology · doi:10.1007/s00415-016-8220-2 · Cited by 45
Reuck, J. D., Deramecourt, V., Cordonnier, C., Auger, F., Durieux, N., Bordet, R., Maurage, C., Leys, D., & Pasquier, F. (2012) · European Journal of Neurology · doi:10.1111/j.1468-1331.2012.03776.x · Cited by 44
Collagen abnormalities in the spinal cord from patients with amyotrophic lateral sclerosis
Ono, S., Imai, T., Munakata, S., Takahashi, K., Kanda, F., Hashimoto, K., Yamano, T., Shimizu, N., Nagao, K., & Yamauchi, M. (1998) · Journal of the Neurological Sciences · doi:10.1016/s0022-510x(98)00223-8 · Cited by 43
Type IV collagen prevents amyloid β-protein fibril formation
Kiuchi, Y., Isobe, Y., & Fukushima, K. (2002) · Life Sciences · doi:10.1016/s0024-3205(01)01528-4 · Cited by 42
Gessel, M. M., Spraggins, J. M., Voziyan, P., Hudson, B. G., & Caprioli, R. M. (2015) · Journal of Mass Spectrometry · doi:10.1002/jms.3696 · Cited by 41
Zekonyte, J., Sakai, K., Nicoll, J. A. R., Weller, R. O., & Carare, R. O. (2015) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2015.08.025 · Cited by 40
Structural characterization of recombinant domain II of the basement membrane proteoglycan perlecan
Costell, M., Sasaki, T., Mann, K., Yamada, Y., & Timpl, R. (1996) · FEBS Letters · doi:10.1016/0014-5793(96)01082-4 · Cited by 40
Prevalence of cerebrovascular lesions in patients with Lewy body dementia: A neuropathological study
Reuck, J. D., Deramecourt, V., Cordonnier, C., Leys, D., Pasquier, F., & Maurage, C. (2012) · Clinical Neurology and Neurosurgery · doi:10.1016/j.clineuro.2012.11.005 · Cited by 39
Wallin, A., Blennow, K., & Rosengren, L. (1999) · Alzheimer Disease & Associated Disorders · doi:10.1097/00002093-199912001-00015 · Cited by 38
Laminin blocks the assembly of wild-type Aβ and the Dutch variant peptide into Alzheimer's fibrils
Bronfman, F. C., Alvarez, A. R., Morgan, C., & Inestrosa, N. C. (1998) · Amyloid · doi:10.3109/13506129809007285 · Cited by 37
Kose, N., Asashima, T., Muta, M., Iizasa, H., Sai, Y., Terasaki, T., & Nakashima, E. (2007) · Drug Metabolism and Pharmacokinetics · doi:10.2133/dmpk.22.255 · Cited by 36
Amyloid Precursor-like Protein 2 Promotes Cell Migration toward Fibronectin and Collagen IV
Li, X.-F., Thinakaran, G., Sisodia, S. S., & Yu, F. X. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.38.27249 · Cited by 36
Decreased type IV collagen of skin and serum in patients with amyotrophic lateral sclerosis
Ono, S., Imai, T., Takahashi, K., Jinnai, K., Yamano, T., Nagao, K., Shimizu, N., & Yamauchi, M. (1998) · Neurology · doi:10.1212/wnl.51.1.114 · Cited by 35
Roher, A. E., Cribbs, D. H., Kim, R. C., Maarouf, C. L., Whiteside, C. M., Kokjohn, T. A., Daugs, I. D., Head, E., Liebsack, C., Serrano, G. E., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0059735 · Cited by 34
Increased albumin CSF/serum ratio in dementia with Lewy bodies
Llorens, F., Schmitz, M., Gloeckner, S. F., Kaerst, L., Hermann, P., Schmidt, C., Varges, D., & Zerr, I. (2015) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2015.10.011 · Cited by 34
Sérot, J., Béné, M. C., Foliguet, B., & Faure, G. C. (1997) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1997.tb48514.x · Cited by 34
A novel decellularization method to produce brain scaffolds
Granato, A. E. C., da Cruz, E. F., Rodrigues‐Junior, D. M., Mosini, A. C., Ulrich, H., Rodrigues, B. V. M., Cheffer, A., & Porcionatto, M. A. (2020) · Tissue and Cell · doi:10.1016/j.tice.2020.101412 · Cited by 33
Cerebral Microbleeds as a Biomarker in Alzheimer’S Disease? A Review in The Field
Shams, S., & Wahlund, L.-O. (2016) · Biomarkers in Medicine · doi:10.2217/bmm.15.101 · Cited by 32
Kurata, T., Miyazaki, K., Kozuki, M., Morimoto, N., Ohta, Y., Ikeda, Y., & Abe, K. (2011) · Neuroscience · doi:10.1016/j.neuroscience.2011.09.030 · Cited by 31
Different Impact of ALS on Laminin Isoforms in Human Extraocular Muscles versus Limb Muscles
Liu, J., Brännström, T., Andersen, P. M., & Domellöf, F. P. (2011) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.10-7132 · Cited by 30
Disassembly of amyloid β-protein fibril by basement membrane components
Kiuchi, Y., Isobe, Y., Fukushima, K., & Kimura, M. (2002) · Life Sciences · doi:10.1016/s0024-3205(02)01501-1 · Cited by 28
Basal Lamina of Abdominal Skeletal Muscle Capillaries in Diabetics and Nondiabetics
Vracko, R., & Strandness, D. E. (1967) · Circulation · doi:10.1161/01.cir.35.4.690 · Cited by 28
Hirose, M., Asano, M., Watanabe-Matsumoto, S., Yamanaka, K., Abe, Y., Yasui, M., Tokuda, E., Furukawa, Y., & Misawa, H. (2020) · Neuroscience Research · doi:10.1016/j.neures.2020.10.006 · Cited by 27
Parham, C. L., Auckland, L. D., Rachwal, J., Clarke, D. N., & Bix, G. J. (2013) · Journal of Alzheimer s Disease · doi:10.3233/jad-130683 · Cited by 25
Self-citationAmyloid angiopathy in idiopathic Parkinson's disease. Immunohistochemical and ultrastructural study.
Bertrand, E., Lewandowska, E., Stępień, T., Szpak, G. M., Pasennik, E., & Modzelewska, J. (2008) · PubMed · Cited by 24
Regenerative effects of peptide nanofibers in an experimental model of Parkinson’s disease
Sever, M., Türkyılmaz, M., Koç, C., Çakır, A., Öcalan, B., Cansev, M., Guler, M. O., & Tekinay, A. B. (2016) · Acta Biomaterialia · doi:10.1016/j.actbio.2016.09.011 · Cited by 22
KDI tripeptide of γ1 laminin protects rat dopaminergic neurons from 6‐OHDA induced toxicity
Väänänen, A. J., Rauhala, P. V., Tuominen, R. K., & Liesi, P. (2006) · Journal of Neuroscience Research · doi:10.1002/jnr.20961 · Cited by 21
New role for Agrin in T cells and its potential importance in immune system regulation
Jury, E. C., & Kabouridis, P. S. (2010) · Arthritis Research & Therapy · doi:10.1186/ar2957 · Cited by 21
Perlecan domain V inhibits α2 integrin-mediated amyloid-β neurotoxicity
Wright, S., Parham, C. L., Lee, B., Clarke, D. N., Auckland, L. D., Johnston, J. A., Lawrence, A. L., Dickeson, S. K., Santoro, S. A., Griswold‐Prenner, I., et al. (2010) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2010.10.018 · Cited by 19
Self-citationLaminin inhibits Aβ40 fibril formation promoted by apolipoprotein E4 in vitro
Monji, A., Tashiro, K., Yoshida, I., Hayashi, Y., & Tashiro, N. (1998) · Brain Research · doi:10.1016/s0006-8993(98)00342-4 · Cited by 19
Deposition of Nidogens and Other Basement Membrane Proteins in the Young and Aging Mouse Retina
Kunze, A., Abari, E., Semkova, I., Paulsson, M., & Hartmann, U. (2009) · Ophthalmic Research · doi:10.1159/000247595 · Cited by 19
Fernández‐Vega, I., Lorente-Gea, L., García, B., Martín, C., & Quirós, L. M. (2017) · Neural Regeneration Research · doi:10.4103/1673-5374.208571 · Cited by 18
Wikstén, M., Väänänen, A. J., & Liesi, P. (2007) · Journal of Neuroscience Research · doi:10.1002/jnr.21314 · Cited by 17
Novel and functional ABCB1 gene variant in sporadic Parkinson’s disease
Li, Y., Li, Y., Pang, S., Huang, W., Zhang, A., Hawley, R. G., & Yan, B. (2014) · Neuroscience Letters · doi:10.1016/j.neulet.2014.02.025 · Cited by 16
The cellular origin of laminin determines its role in blood pressure regulation
Yao, Y., Norris, E. H., & Strickland, S. (2014) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-014-1732-y · Cited by 16
Self-citationRao, J. S., Hantaı̈, D., & Festoff, B. W. (1992) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(92)90271-l · Cited by 15
Parham, C. L., Shaw, C., Auckland, L. D., Dickeson, S. K., Griswold‐Prenner, I., & Bix, G. J. (2016) · Journal of Alzheimer s Disease · doi:10.3233/jad-160290 · Cited by 15
Self-citationIncreased Expression of Laminin 1 in the Skin of Amyotrophic Lateral Sclerosis
Ono, S., Imai, T., Shimizu, N., & Nagao, K. (2000) · European Neurology · doi:10.1159/000008178 · Cited by 15
Timmer, N., Herbert, M. K., Kleinovink, J. W., Kiliaan, A. J., de Waal, R. M. W., & Verbeek, M. M. (2010) · Neuropathology and Applied Neurobiology · doi:10.1111/j.1365-2990.2010.01091.x · Cited by 14
van Horssen, J., de Vos, R. A. I., Steur, E. N. H. J., David, G., Wesseling, P., de Waal, R. M. W., & Verbeek, M. M. (2004) · Journal of Alzheimer s Disease · doi:10.3233/jad-2004-6502 · Cited by 13
Soluble KDI domain of γ1 laminin protects adult hippocampus from excitotoxicity of kainic acid
Wikstén, M., Väänänen, A. J., Liebkind, R., Rauhala, P. V., & Liesi, P. (2004) · Journal of Neuroscience Research · doi:10.1002/jnr.20158 · Cited by 12
Matsuda, K., Tashiro, K., Hayashi, Y., Monji, A., Yoshida, I., & Mitsuyama, Y. (2002) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000063601 · Cited by 12
de Mesquita, D. A. K., Queiroz, É. F., de Oliveira, M. A., da Cunha, C. M. Q., Fernanda Martins, M. A. I. A., & Corrêa, R. V. (2018) · Arquivos de Gastroenterologia · doi:10.1590/s0004-2803.201800000-81 · Cited by 12
Distribution of Nidogen in the Murine Eye and Ocular Phenotype of the Nidogen-1 Knockout Mouse
May, C. A. (2012) · ISRN Ophthalmology · doi:10.5402/2012/378641 · Cited by 10
Genetic mapping of the ?1 and ?2 (IV) collagen genes to mouse Chromosome 8
Filie, J. D., Burbelo, P. D., & Kozak, C. A. (1995) · Mammalian Genome · doi:10.1007/bf00360662 · Cited by 10
Kuo, D. S., Labelle‐Dumais, C., Mao, M., Jeanne, M., Kauffman, W. B., Allen, J., Favor, J., & Gould, D. B. (2014) · Europe PMC (PubMed Central) · doi:10.1093/hmg/ddt560 · Cited by 3
Shinpo (2000) · doi:10.1002/1097-4547(20001101)62:3
Cited by
Sorted by citations
ApoE4 reduction: An emerging and promising therapeutic strategy for Alzheimer's disease
Li, Y., Macyczko, J. R., Liu, C.-C., & Bu, G. (2022) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2022.03.011 · Cited by 61
Metadata
- Authors
- Nguyen, B., Bix, G., & Yao, Y.
- Affiliations
- University of Georgia (US)
- Tulane University (US)
- Corresponding author
- Yao, Yao
- Venue
- Molecular Neurodegeneration
- Published
- 2021-12-07
- Volume
- 16
- Issue
- 1
- Pages
- 81-81
- ISSN
- 1750-1326 (ISSN-L)
- PMC
- PMC8650282
- OpenAlex
- W4200551731
- Cited by
- 75
- References
- 354
- Citations by year
- 2026: 9 · 2025: 23 · 2024: 16 · 2023: 13 · 2022: 14
- FWCI
- 1.27
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- Molecular Neurodegeneration (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- National Heart, Lung, and Blood Institute (R01HL146574)
- National Institute on Aging (R21AG064422, R21AG073862, RF1AG065345)
- American Heart Association (16SDG29320001)
- Topics
- Life Sciences › Neuroscience › Neurology › Barrier Structure and Function Studies
- Health Sciences › Medicine › Clinical Neurology › Cerebrospinal fluid and hydrocephalus
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Keywords
- basement membrane, neurodegenerative diseases, blood-brain barrier, Alzheimer's disease, Parkinson's disease, amyotrophic lateral sclerosis, aging, meningeal lymphatic system, glymphatic system, protein clearance, protein aggregation, perivascular spaces, therapeutic target
- MeSH terms
- Glymphatic System, Alzheimer Disease, Basement Membrane, Blood-Brain Barrier, Humans, Neurodegenerative Diseases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review